Interpretation of Discordant ESR and CRP in the Recovery Phase

Kinetics of Inflammatory Markers

C‑reactive protein (CRP) normalizes more rapidly than erythrocyte sedimentation rate (ESR) during resolution of inflammation, making a pattern of normal CRP with persistently elevated ESR a common and expected finding in recovering inflammatory conditions. 1, 2
ESR reflects fibrinogen concentrations; because fibrinogen has a longer half‑life, ESR values typically decline over weeks to months after the inciting inflammation has resolved. 1, 2

In patients who experienced an acute inflammatory event (e.g., infection, autoimmune flare, postoperative inflammation) approximately three months earlier, a normalized CRP together with an elevated ESR most likely indicates that the inflammation is resolving rather than active. 1, 2
CRP is more sensitive for monitoring treatment response in acute inflammatory conditions, whereas ESR lags and therefore is less useful for early assessment of therapeutic effect. 1, 2
After completion of therapy, CRP usually returns to normal several weeks before ESR does, which may remain elevated for months despite clinical remission. 1, 2

Development of new or worsening symptoms suggestive of active inflammation (e.g., fever, pain, functional decline, new organ involvement) should prompt additional diagnostic work‑up. 3, 4
Presence of risk factors for chronic inflammatory diseases (such as rheumatoid arthritis, inflammatory bowel disease, or vasculitis) that have not been fully assessed warrants further investigation. 3, 4, 5

When the patient is asymptomatic, CRP is normal, and a non‑inflammatory contributor (e.g., anemia, renal insufficiency, hypoalbuminemia) is identified, repeat both ESR and CRP in 4–8 weeks to confirm a downward trend. 6
If the patient is symptomatic or ESR continues to rise, pursue disease‑specific evaluation based on the clinical presentation. 3, 4

Do not infer active inflammation solely from an elevated ESR when CRP is normal, especially during the convalescent phase of a previously treated condition. 1, 2
Intravenous immunoglobulin (IVIG) therapy can cause a prolonged ESR elevation for several weeks, limiting its reliability for monitoring response in conditions such as Kawasaki disease. 1, 2